Despite receiving a sub-therapeutic administered activity, his PSA value decreased after normalization of kidney function (Additional file 1: Figure S2B) and his ECOG performance improved from 3 to 1, suggesting anti-tumor treatment effect. The gene discussed is KLK3; the disease is neoplasm.